Asia Fresh News

Asia Fresh Stories

Archive for May 13th, 2015

Synpulse a Global Leader in Management Consultancy for Financial Service Providers, Appoints Dr. Christoph Nutzenadel as Chief Executive Officer

leave a comment »

-Outgoing CEO Michael Gerber to lead Synpulse in Asia as the company opens its first Hong Kong office and expands its team of experts to drive regional growth

SINGAPORE /PRNewswire/ — Synpulse, one of the leading management consulting companies in the Financial Services sector, today announced the appointment of Dr. Christoph Nutzenadel as new Chief Executive Officer. From 1st July, Mr. Nutzenadel will lead a team of more than 200 in the USA, Switzerland,Germany and Singapore. Outgoing CEO Mr. Michael Gerber will head the company’s growing operations in Asia.

Since opening its first office in Switzerland in 1996, Synpulse has expanded steadily to become a management consultant and partner to some of the world’s leading Financial Services institutions, Mr Nutzenadel said. This has only been possible with the right team, he added, paying homage to Mr. Gerber’s role in the company’s growth.

“Michael designed and implemented the internationalization of the company,” said Mr. Nutzenadel. “What was once a Swiss company located in Zurich has become a multinational company on three continents with around 200 employees. Michael has set a clear path for me and I’m looking forward to steering a team knowing that we have the best leaders in each key market to drive our growth and service standards.”

Expanding Global Footprint
In his new role as the head of Asia, Michael will focus on implementing the company’s expansion strategy. Immediately after his appointment, Synpulse announced the opening of its fifth global office in Hong Kong under the leadership of Mr. Marco Kamerling, a proven leader and an insurance expert who relocates from Synpulse’s office in Switzerland. Michael, who has been in Asia for more than two years leading the Singapore team, has been recruiting aggressively in the region to strengthen the company’s pool of expertise that currently stands around 60 employees in Singapore.

With the opening of the new Hong Kong office, opportunities to improve service to existing clients and acquire new ones are key priorities. “Each market is significant to Synpulse,” Michael said. “We have a team of world-class experts in each, and with Christoph now taking the global leadership role, it gives me the required time to focus on Asia. The market here is incredibly distinct with incredible opportunities and interesting challenges. We’re very excited about our foray into this part of the world.”

Top Experts to Boost Asian Growth
Two senior experts have been added to the Synpulse team in Asia to support the expansion plan. The firm has brought on board Mr. Patrick Lam, an insurance and banking veteran to strengthen the Hong Kong management team; Mr. Vikas Seth, a highly seasoned business transformation expert to distinctly widen the current service offerings of Synpulse in Singapore in the private banking sector.

“Synpulse has always taken pride in the fact that its team is the firm’s point of difference — a team that has exceptional academic fundamentals, a strong understanding of their client’s needs and its ability to provide strategic and tactical solutions,” added Michael. “With these two gentlemen we now have the pleasure of working with have enviable portfolios. Each one has their areas of expertise and strengths and they will both individually and collectively play a significant part in our new direction. We are certain that with the years of experience and skills Vikas and Patrick bring to Synpulse, we are demonstrating to our clients our commitment to delivering unrivalled service.”

About Synpulse
Synpulse is an internationally established management consulting company and valued partner of many of the world’s largest financial services providers. Since its founding in 1996, Synpulse supports banks and insurers along the entire value chain; from the development of strategies and their operative realization, to technical implementation and hand-over. Synpulse is characterized by in depth industry knowledge and the passion and commitment of its 200 employees, who come from more than 20 countries. Synpulse is represented with locations in Zurich, Hamburg, Singapore, New York and Hong Kong.

For Media Enquiries and Interviews, please contact:
Wani Diwarkar, PR Bespoke, +65-9832-0643 or

Synpulse Singapore Pte. Ltd.
Management Consulting
8 Shenton Way  #46-01 AXA Tower
Singapore 068811
Phone +65 6229 5770,

Source: Synpulse
Related Links:

Written by asiafreshnews

May 13, 2015 at 5:06 pm

Posted in Uncategorized

MediaTek Launches the MediaTek Helio(TM) X20: The World’s First Mobile SoC Featuring Tri-Cluster(TM) CPU Architecture

leave a comment »

Innovative three cluster architecture sets new performance and power efficiency benchmarks with up to a 30% reduction in power consumption for the next generation of mobile devices

HSINCHU /PRNewswire/ — MediaTek today announces the launch of the MediaTek Helio™ X20 — the world’s first mobile processor with Tri-Cluster™ CPU architecture and ten processing cores (Deca-core). The Helio X20 continues MediaTek’s mission of delivering industry-leading computing performance coupled with unmatched power efficiency. With the integration of MediaTek’s WorldMode Category 6 LTE modem with carrier aggregation and upgraded CorePilot® 3.0 advanced scheduling algorithm, the Helio X20 is set to revolutionize the mobile processor industry and address the global demand for flagship mobile devices. The Helio X20 is expected to be available in consumer products by end of this year.

Today’s mobile devices are being asked to perform a wider range of tasks than ever before.  Gaming requires sustained high-performance, advanced imaging and video recording need bursts of peak processor power, which are heavy load tasks. These are coupled with lighter load tasks, such as Internet browsing and audio. Battery life is also of paramount importance to all types of users. Yet existing mobile processing architectures don’t efficiently meet the wide spectrum of use case scenarios. Currently, most high-end smartphones use dual cluster architectures, which limit the extent of the lowest power at one end and the computing granularity across the different configurations.

MediaTek’s Tri-Cluster CPU architecture in the Helio X20 provides three processor clusters, each designed to more efficiently handle different types of workloads. The Tri-Cluster CPU consists of one cluster of two ARM Cortex-A72 cores (running at 2.5GHz for extreme performance) and two clusters of four ARM Cortex-A53 cores (one running at 2.0GHz for medium loads and one running at 1.4GHz for light activities). Much like adding gears to vehicles, dividing the cores into three clusters provides a more efficient allocation of tasks for optimum performance and extended battery life.

The Tri-Cluster CPU architecture is enabled by MediaTek’s new CorePilot 3.0 heterogeneous computing scheduling algorithm. CorePilot 3.0 schedules the tasks for all CPUs and GPUs on the SoC while managing power and thermal effects so that extreme performance can be attained while creating less heat. It provides up to a 30% reduction of power consumption compared with conventional dual cluster architectures.

“By leading with mobile CPU architecture and multimedia innovation, MediaTek continues to push the envelope of power efficiency and peak performance,” said Jeffrey Ju, Senior Vice President of MediaTek. “We are excited to see device manufacturers raise the bar — in camera, display, audio and other consumer features. MediaTek has been adding innovative multimedia features to our platforms since the very beginning, enhancing the overall computing and multimedia experience as part of our strategy to put leading technology into the hands of everyone.”

MediaTek’s Helio X20 boasts several unrivaled features designed to maximize device display performance and enhance the multimedia experience for the consumer. Advanced features include:

  • Dual main cameras with a built-in 3D depth engine that allows for a faster shot-to-shot experience in creating complex depth-of-field images.
  • Multi-scale de-noise engines to deliver high quality images with unprecedented detail, color accuracy, and sharpness even under extreme conditions.
  • A 120Hz mobile display that breaks the barriers of the current 60Hz refresh rate to provide crisp and responsive browsing and uncompromised motion viewing.
  • An integrated, low power sensor processor – ARM Cortex-M4 – to support diverse always-on applications such as MP3 playback and voice activation. The sensor hub operates on an isolated, low power domain to assist with tasks for better battery efficiency.

MediaTek Helio X20 will sample in Q3 2015 and is expected to be available in consumer products by end of this year. For more details about the Helio X20, please visit:

About MediaTek Inc.

MediaTek is a pioneering fabless semiconductor company, and a market leader in cutting-edge Systems on Chip for wireless communications and connectivity, HDTV, DVD and Blu-ray. MediaTek created the world’s first True 8Core™ smartphone platform with LTE and our CorePilot® technology releasing the full power of multi-core mobile processors. Through MediaTek Labs, the company is creating a worldwide ecosystem in support of device creation, application development and services based around MediaTek offerings. With an emphasis on enabling technology for the masses and not the chosen, everyone can be an Everyday Genius®. MediaTek [TSE:2454] is headquartered in Taiwan and has offices worldwide. Please visit for more information.

MediaTek Press Office:

Kristin Taylor, MediaTek
2860 Junction Ave, San Jose, CA 95134, USA

Joey Lee, MediaTek
+886-3-567-0766 # 31602
No. 1, Dusing 1st Rd., Hsinchu Science Park, Hsinchu City 30078, Taiwan

Source: MediaTek Inc.
Related Links:

Written by asiafreshnews

May 13, 2015 at 4:12 pm

Posted in Uncategorized

Culture Trumps CEO Charisma for Delivering Value in a Volatile World

leave a comment »

— The Success Formula identifies evidence-led culture as essential to strategy implementation

CHICAGO, May 12, 2015 /PRNewswire/ — A two-year research collaboration between Heidrick & Struggles (NASDAQ: HSII), the premier provider of executive search, leadership consulting and culture shaping worldwide, and a leading business author explores how senior executives around the world can improve value delivery in an era of unprecedented volatility and change.

The Success Formula: How Smart Leaders Deliver Outstanding Value (Bloomsbury Publishing) reveals that the most successful organizations are not those led by charismatic and visionary leaders, but by leaders who create a culture of delivering outstanding value.

Andrew Kakabadse, Professor of Governance and Leadership at Henley Business School in the UK and the author of 43 business and leadership books, embarked on a global study with consultants at Heidrick & Struggles to examine the link between leadership and sustainable business value. Together, they interviewed more than 100 chairmen, board directors, chief executives and senior executives in the public, private and third sectors in 14 countries.

“In today’s VUCA world – that is to say, volatile, uncertain, complex and ambiguous – a business leader needs to build a culture that is driven to create value, and to transform personal vision into the organization’s purpose,” said Steve Mullinjer, Regional Leader, Asia Pacific, Heidrick & Struggles and co-leader of The Success Formula research project. “Our research clearly shows the importance of culture and purpose in an organization that successfully delivers the leader’s strategy.”

Kakabadse shows that smart leaders who sustain success over a long period drive strategy in an ‘evidence-led’ approach instead of a ‘strategy-led’ one.

“Even in the age of Big Data, many important decisions are still based on prejudices, preconceptions, entrenched beliefs, outdated worldviews, and even ego,” Kakabadse said. “In contrast, smart leaders create an evidence-led culture in the organization that generates sustainable value.”

According to The Success Formula, three qualities are essential for value-delivery leaders:

Not just diversity, but diversity of thinking
Increasing the diversity of a leadership team in terms of gender, ethnicity and other demographic factors undoubtedly leads to more creative and broad-minded thinking. High-performing organizations, however, recognize that these benefits will not stick unless the organization creates a process around diversity of thinking to instill a culture that welcomes wide-ranging experiences, viewpoints and interests.

Leadership through alignment and engagement
The effective implementation of a strategy requires top-down engagement and alignment, as well as bottom-up feedback within the organization to test and modify the strategy. During this process, leaders need to facilitate engagement so that people are willing to voluntarily invest their efforts to position the organization to achieve its strategic objectives.

Evidence-led action
Effective leaders critically examine evidence and interrogate the issues through quality data. They recognize the importance of contextual (soft) evidence as well as intellectual (hard) evidence, and seek to test any strategy before it goes live. They make a habit of debating the evidence with their teams to challenge their thinking.

About Heidrick & Struggles
Heidrick & Struggles (Nasdaq: HSII) serves the executive talent and leadership needs of the world’s top organizations as the premier provider of leadership consulting, culture shaping and senior-level executive search services. Heidrick & Struggles pioneered the profession of executive search more than 60 years ago. Today, the firm serves as a trusted advisor, providing integrated leadership solutions and helping its clients change the world, one leadership team at a time.

H&S Media Contacts:
Lia Randazzo – 312.496.1788,
Karen Lau – +852 2103 9329,

Logo –

Source: Heidrick & Struggles
Related stocks: NASDAQ-NMS:HSII

Written by asiafreshnews

May 13, 2015 at 3:37 pm

Posted in Human Resources

Annual AAJA Asia Chapter Conference In The Dynamic South Korean Capital, Seoul, May 22-24!

leave a comment »

SEOUL, South Korea /PRNewswire/ — This innovative media conference with an eye to the evolving digital landscape takes the “New. Now. Next.” theme to topics including ‘How to Cover North Korea,‘ ‘Future of Digital Content,‘ ‘Asia Start-up Boom,‘ and ‘What’s your Social Network Strategy.’

A premier selection of Asia’ Leading voices in Journalism and Media
A premier selection of Asia’ Leading voices in Journalism and Media

Over 150 journalists from around the region will participate in a weekend of workshops, panels, networking meals and tour programs. Sponsors include Google, AP, Bloomberg, d.Camp and CJ E&M. Speakers and Panelists include Angie Lau, Steve Herman, Paul Cheung, Ken Moritsugu, Ted Anthony and much more.

The conference begins Friday evening at Google Korea’s headquarters where we will have cocktails, food and a reception featuring Korea’s top YouTube stars including EatYourKimchi. YouTube Korea will also present ‘What Newsrooms Don’t Get about YouTube.’

On Saturday, the N3CON venue moves to one of Seoul’s hottest start-up accelerators, d.CAMP. For a full day we will discuss the future of journalism in the age of the digital newsroom. Get ready to share your best practices with journalists from print, broadcast, radio and new media. And get ready to learn some new technical skills, discover more about regional Asia issues or get advice on how to advance your career.

Sunday will be your day to explore all that Seoul has to offer. We will provide access to an optional tour of the inter-Korean border, the DMZ. For those who want to focus on exploring the new tech city that Seoul has become, we will have a free city tour on offer.

Register early to get the discounted rates. Registration includes Friday’s reception (including reception food and drinks), Saturday’s events (including breakfast and lunch), and Sunday’s city tour. Extra fees will be collected for the Saturday night award dinner and Sunday’s DMZ tour. Additional expenses for entertainment after the conference events on Friday and Saturday night are paid by each attendee based on their wishes. Travel and accommodation must be arranged by each participant on their own.

Members get extra discounts! You may join AAJA before you register for the conference. Membership is open to all. You don’t have to be Asian, American, or even a current working journalist based on the traditional definition. Event attendees are mainly those who work in the journalism field. But we understand that the constantly evolving nature of the industry along with the accelerated velocity brought by digital storytelling has removed old borders and formed new categories within our profession that are still being formed.

So join us in Seoul! May 22-24, 2015. Tickets can be purchased online at For more information,

Xiaoming Jiao

Photo –
Logo –

Source: The Asian American Journalists Association
Related Links:

Written by asiafreshnews

May 13, 2015 at 3:17 pm

Posted in Uncategorized

Merck Receives FDA Fast Track Designation for Evofosfamide for Treatment of Patients Living With Advanced Pancreatic Cancer

leave a comment »

DARMSTADT, Germany, May 12, 2015 /PRNewswire/ —


Evofosfamide is an investigational compound currently in Phase III trials
Advanced pancreatic cancer is second indication to receive FDA fast track designation for evofosfamide
Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of evofosfamide (previously known as TH-302), administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally advanced unresectable pancreatic cancer. Evofosfamide is an investigational hypoxia-activated prodrug thought to be activated under severe tumor hypoxic conditions, a feature of many solid tumors. The compound, currently in Phase III trials, is being developed in collaboration with Threshold Pharmaceuticals, Inc.

Merck over the past years has bolstered its growth platforms in healthcare, life science and performance materials to provide solutions in areas with high demand for innovation. In its biopharmaceuticals business, the company has strengthened its research and development activities and is increasingly counting on partnerships to optimize relevance and efficiency.

“Merck is focused on discovering and developing innovative new therapeutic options for cancers that are particularly difficult to treat,” said Luciano Rossetti, Head of Global Research and Development of Merck’s biopharmaceutical business, Merck Serono. “Many patients with pancreatic cancer present with advanced, inoperable tumors, and there are limited treatment options currently available for them. The Fast Track designation for evofosfamide in pancreatic cancer – the second indication for this compound to receive Fast Track designation from the FDA, following the granting of the designation in soft tissue sarcoma – will help to facilitate the timely development of this high-priority program for Merck Serono.”

Threshold received the first Fast Track designation for the development of evofosfamide in combination with doxorubicin for the treatment of advanced soft tissue sarcoma in November 2014.

“We are pleased that evofosfamide has been granted Fast Track status for the treatment of patients living with pancreatic cancer,” said Barry Selick, Ph.D., Chief Executive Officer of Threshold Pharmaceuticals, Merck’s co-development partner. “Evofosfamide is currently being studied in patients with pancreatic cancer in the MAESTRO Phase III study, and based on current projections, we expect that the number of protocol-specified events for the trial may be reached in the second half of 2015, with the results of the primary efficacy analyses to be available shortly thereafter.”

The FDA established the Fast Track designation process to facilitate the development and expedite the review of drugs intended to treat serious or life-threatening conditions that demonstrate the potential to address unmet medical needs.

Pancreatic cancer is a relatively uncommon, but lethal cancer.[1] Ranked as the 12th most common cancer worldwide, it is the 7th most common cause of cancer-related death, accounting for 4% of deaths.[1] With 93-95% of patients dying from their disease within 5 years, pancreatic cancer has a low survival rate.[2],[3] There has been little improvement seen in the survival of patients with this disease over the past 30 years[4] and there remain limited treatment options for pancreatic cancer.[5] Surgery remains the only curative approach for pancreatic cancer;[5] however, many patients (80-85%) present with advanced, inoperable disease.[6] For this large group of patients ineligible for surgery, the aim of treatment is prolongation of survival and palliation of symptoms.[7]


Ferlay J, et al. Int J Cancer 2015;136(5):E359-86.
National Cancer Institute. SEER Stat Fact Sheets: Pancreas. Available at: Accessed: May 2015.
EUROCARE-4 database on cancer survival in Europe. Long-term survival expectations of cancer patients in Europe in 2000-2002. Available at: Accessed: May 2015.
Siegel R, et al. CA Cancer J Clin 2012;62(1):10-29.
Malik NK, et al. J Gastrointest Oncol 2012;3(4):326-34.
Loc WS, et al. World J Gastroenterol 2014;20(40):14717-25.
Seufferlein T, et al. Ann Oncol 2012;23(Suppl 7):vii33-40.
For more information on Merck Serono in oncology, please visit:

About Evofosfamide

Evofosfamide (previously known as TH-302) is an investigational hypoxia-activated prodrug that is thought to be activated under severe tumor hypoxic conditions, a feature of many solid tumors. Areas of low oxygen levels (hypoxia) in solid tumors are due to insufficient blood vessel supply. Similarly, the bone marrow of patients with hematological malignancies has also been shown, in some cases, to be severely hypoxic.

Evofosfamide is currently under evaluation in two Phase III trials: one in combination with doxorubicin versus doxorubicin alone in patients with locally advanced unresectable or metastatic soft tissue sarcoma (the TH-CR-406 trial), and the other in combination with gemcitabine versus gemcitabine and placebo in patients with locally advanced unresectable or metastatic pancreatic cancer (the MAESTRO trial). Both Phase III trials are being conducted under Special Protocol Assessment (SPA) agreements with the FDA. The FDA and the European Commission have granted evofosfamide Orphan Drug designation for the treatment of STS and pancreatic cancer. The FDA has also granted Fast Track designation for evofosfamide for both STS and pancreatic cancer. Evofosfamide is also being investigated in a Phase II trial for the treatment of non-squamous non-small cell lung cancer, and in earlier-stage clinical trials of other solid tumors and hematological malignancies.

Merck signed a global license and co-development agreement for evofosfamide with Threshold Pharmaceuticals, Inc. in February 2012, with an option for Threshold to co-commercialize in the U.S.

Evofosfamide is currently under clinical investigation and has not been approved for use in the U.S., Europe, Canada, or elsewhere. Evofosfamide has not yet been proven to be either safe or effective and any claims of safety and effectiveness can be made only after regulatory review of the data and approval of the labeled claims.

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to to register online, change your selection or discontinue this service.

Merck is a leading company for innovative, top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses – Merck Serono, Consumer Health, Allergopharma, Biosimilars, Merck Millipore and Performance Materials – and generated sales of around € 11.3 billion in 2014. Around 39,000 employees work for Merck in 66 countries to improve the quality of life for patients, to further the success of customers, and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company operates as EMD Serono, EMD Millipore and EMD Performance Materials.

Source: Merck KGaA

Written by asiafreshnews

May 13, 2015 at 3:17 pm

Posted in Healthcare

Stratasys Additive Manufacturing Solutions Selected by Airbus to Produce 3D Printed Flight Parts for Its A350 XWB Aircraft

leave a comment »

HONG KONG /PRNewswire/ — Stratasys Ltd. (Nasdaq:SSYS), a leading global provider of 3D printing and additive manufacturing solutions, announces that leading aircraft manufacturer Airbus has produced more than 1,000 flight parts on its Stratasys FDM 3D Production Systems for use in the first-of-type A350 XWB aircraft, delivered in December 2014. The 3D printed parts were used in place of traditionally manufactured parts to increase supply chain flexibility, enabling Airbus to meet its delivery commitment on-time.  Airbus initiated development and certification of 3D printing with Stratasys in 2013 as a schedule risk reduction activity that proved valuable for the A350 XWB program, highlighting a key benefit of 3D printing in the manufacturing industry.

The parts are 3D printed using ULTEM™ 9085 resin for FDM, which is certified to an Airbus material specification. ULTEM 9085 resin provides high strength-to-weight ratio and is FST (flame, smoke and toxicity) compliant for aircraft interior applications. This enables Airbus to manufacture strong, lighter weight parts while substantially reducing production time and manufacturing costs.

“We are delighted that Stratasys additive manufacturing solutions are being adopted by Airbus for its flagship A350 XWB aircraft. Both companies share a vision of applying innovative technologies to design and manufacturing to create game-changing benefits,” said Dan Yalon, Executive Vice President, Business Development, Marketing & Vertical Solutions for Stratasys. “Our additive manufacturing solutions can produce complex parts on-demand, ensuring on time delivery while streamlining supply chains.  Additive manufacturing also greatly improves the buy-to-fly ratio as significantly less material is wasted than with conventional manufacturing methods. Stratasys is looking forward to bringing these and other advantages to its collaboration with Airbus and to being part of Airbus’ Factory of the Future initiative.”

Leading companies in a variety of industries, from aerospace and automotive to consumer goods and medical, are partnering with Stratasys to adopt additive manufacturing strategies. A transformative alternative to conventional manufacturing methods, Stratasys additive manufacturing enables original and replacement parts to be digitally produced at the best suited locations, reducing both material waste and inventory requirements. By adopting additive manufacturing throughout the product lifecycle, companies can therefore lower operational costs, accelerate time to market, decentralize production, and add new innovative product functionality.

Stratasys Ltd. (Nasdaq:SSYS), headquartered in Minneapolis, Minnesota and Rehovot, Israel, is a leading global provider of 3D printing and additive manufacturing solutions. The company’s patented FDM® and PolyJet™ 3D Printing technologies produce prototypes and manufactured goods directly from 3D CAD files or other 3D content. Systems include 3D printers for idea development, prototyping and direct digital manufacturing. Stratasys subsidiary includes MakerBot, and the company operates the digital parts manufacturing service, Stratasys Direct Manufacturing. Stratasys has more than 2,800 employees, holds over 600 granted or pending additive manufacturing patents globally, and has received more than 25 awards for its technology and leadership. Online at: or

FDM, Stratasys and Fortus are registered trademarks of Stratasys Ltd. and/or its subsidiaries or affiliates. ULTEM™ 9085 resin is a registered trademark of SABIC or its affiliates or subsidiaries. All other trademarks are the property of their respective owners.

Attention Editors, if you publish reader-contact information, please use:



Europe/Middle East/Africa


Asia Pacific

+852 39448888

Stratasys Media Contacts


Aaron Masterson
Weber Shandwick
Tel. +1-952-346-6258


Jonathan Wake / Miguel Afonso

UK Bespoke

Tel: +44-1737-215200


Arita Mattsoff / Joe Hiemenz


Tel. +972-(0)74-745-4000 (IL)

Tel. +1-952-906-2726 (US) 

Asia Pacific

Stratasys AP

Janice Lai

Tel. +852-3944-8888  


Stratasys Japan

Aya Yoshizawa

Tel. +81-90-6473-1812


Stratasys Korea

Janice Lai

Tel. +852-3944-8888

Greater China
Stratasys Shanghai
Icy Xie
Tel. +86-21-2601-8886


Stratasys Mexico
Erica Massini
Tel. +55-11-2626-9229  


Tatiana Fonseca

GAD Communications

Tel: +55-11-3846-9981  

Logo –

Source: Stratasys AP

Related stocks: NASDAQ-NMS:SSYS

Related Links:

Written by asiafreshnews

May 13, 2015 at 12:46 pm

Posted in Uncategorized

Vizury and adjust Announce Their Integration to Power-up Measurements for Vizury’s App User Retargeting Solution

leave a comment »

BANGALORE, May 12, 2015 /PRNewswire/ — Vizury and adjust today announced their integration enabling performance measurement and attributions for Vizury’s app user retargeting campaigns. Vizury, a premier performance marketing and retargeting firm, helps over 200 brands worldwide realize their mobile marketing ROI. adjust is a leading business intelligence platform for mobile app marketers, combining attribution for advertising sources with advanced analytics and store statistics.


“Online purchases today are moving rapidly towards the mobile app channel and hence app user retargeting is a powerful approach for brands to boost their mobile ROI . adjust’s mobile measurement platform enables advanced measurement and attribution mechanisms for our mobile app retargeting campaigns providing superior business intelligence to our clients. Additionally, brands that have integrated with adjust will be able to opt for our SDK-less retargeting solution,” said Shiju Mathew, Head of Product – Mobile at Vizury.

“We believe that user-centric attribution is the key to accurate measurement and analytics which are crucial for businesses today. We’re pleased to provide Vizury with additional mobile measurement and analytics capacity, and look forward to delivering valuable app measurements and statistics for Vizury’s campaigns,” said Simon Kendall, Head of Communications at adjust.

Vizury’s mobile retargeting solution helps brands reach users who have dropped off their mobile website and apps with personalized ads on other mobile websites and apps including Facebook.

About Vizury:

Vizury, a premier performance marketing and retargeting firm, helps marketers secure customers using personalized marketing solutions across channels. Established in 2008, we work with some of the best known brands in 40+ countries across industries like travel & hospitality, ecommerce, healthcare, automobile and classifieds. Listed on Deloitte APAC Tech Fast500 for two consecutive years (2013 & 2014), Vizury is among the first companies in Asia to be badged a Facebook Marketing Partner with an FBX specialty and a Twitter Retargeting Platform Partner.

For more information, please visit

Follow Vizury on LinkedIn or on Twitter @vizuryonetoone .

About Adjust:

adjust is a mobile attribution and analytics company from Berlin with offices in San Francisco, Istanbul, Tokyo, and Shanghai. Their business intelligence platform lets app marketers identify the sources of their most valuable users. An official Facebook Mobile Measurement Partner, adjust is integrated with over 500 networks. Clients include Uber, Spotify and Viacom.

Media Contact:
Namrutha Ramanathan

Source: Vizury

Written by asiafreshnews

May 13, 2015 at 11:57 am

Posted in Computer

Katherine McNamara Plays Female Lead as ‘Clary Fray’ in SHADOWHUNTERS

leave a comment »

BURBANK, California and MUNICH, May 12, 2015 /PRNewswire/ —

Dominic Sherwood, Alberto Rosende, Emeraude Toubia, Matthew Daddario and Isaiah Mustafa are also part of the cast

Constantin Film and ABC Family have found their ‘Clary’ in Katherine McNamara. McNamara was recently seen starring in the feature film “New Year’s Eve” and will be seen next in the feature film “Maze Runner: The Scorch Trials” and this summer on ABC Family’s hit series “The Fosters.”

Based on the bestselling young adult fantasy book series The Mortal Instruments by Cassandra Clare, SHADOWHUNTERS follows 18-year-old Clary Fray, who finds out on her birthday that she is not who she thinks she is but rather comes from a long line of Shadowhunters – human-angel hybrids who hunt down demons.

Beautiful, creative, and intelligent, Clary Fray is a promising art student whose bright future is derailed when her mother is kidnapped and she learns her life has been a lie. Clary is thrown into the world of demon hunting with mysterious Shadowhunter Jace and her best friend Simon. Now living among faeries, warlocks, vampires and werewolves, Clary begins a journey of self-discovery as she learns more about her past and what her future may hold. She quickly learns to navigate in this hidden Shadow World full of unthinkable danger. As she is forced into action, she embraces her newfound powers and realizes that she will play the central role in this new world.

SHADOWHUNTERS is executive produced by Ed Decter, McG, Robert Kulzer from Constantin Film, Michael Lynne and Robert Shaye from Unique Features, Marjorie David and Michael Reisz and produced by Don Carmody, David Cormican and Martin Moszkowicz from Constantin Film. McG will also direct the first episode. The network has previously announced Dominic Sherwood (“Vampire Academy”) for the role of ‘Jace,’ Alberto Rosende as ‘Simon’, Emeraude Toubia as ‘Isabelle Lightwood’, Matthew Daddario (“Delivery Man”) as ‘Alec Lightwood’ and Isaiah Mustafa (“Horrible Bosses”) as ‘Luke Garroway.’

About Constantin Film

Constantin Film has been synonymous with quality and success for over 30 years. It has played a crucial role in establishing German cinema both nationally and internationally. Between 1977, when Bernd Eichinger established the company, and 2009, when it was integrated into media conglomerate Constantin Medien AG, Constantin Film has emerged as the most successful independent production and distribution company in the German media industry. Constantin Film’s operations include German and English-language motion picture theatrical production, theatrical distribution, home entertainment distribution, licensing and television production.

Constantin Film’s diverse slate includes box office hits and award-winning films alike, ranging from comic book to literary adaptations, historical dramas, action and genre. Among them are THE NEVERENDING STORY, THE FANTASTIC FOUR film franchise, THE NAME OF THE ROSE, NOWHERE IN AFRICA, DOWNFALL, THE BAADER MEINHOF COMPLEX, THE HOUSE OF SPIRITS, the RESIDENT EVIL film franchise, FACK JU GOHTE and LOVE, ROSIE.

If you have any further queries, please do not hesitate to contact us:

Constantin Film
Telephone: +49-89-44-44-60-100

Source: Constantin Film

Written by asiafreshnews

May 13, 2015 at 11:29 am

Posted in Entertainment

NBA Champion’s L.I.F.E. Beverage Secures Lucrative Mainland China, Hong Kong Distribution Deal With A.S. Watson Through MWFC Global Ventures Hong Kong Ltd.

leave a comment »

HONG KONG, May 12, 2015 /PRNewswire/ — A sizeable distribution agreement was announced today between MWFC Global Ventures Hong Kong Limited (MWFC HK Ltd.) and leading Hong Kong and China beverage distributor, A.S. Watson Group and A.S. Watson Industries (ASWI). The agreement, brokered by Carlsbad California based, the Waters Group LLC, grants ASWI exclusive sales and distribution rights to Let It Fly Energy (L.I.F.E), a US functional beverage brand owned by 2X NBA Champion Mike Miller, currently with the Cleveland Cavaliers. L.I.F.E., whose exclusive rights are held by MWFC HK Ltd., will be available for sale in over 100,000 retail locations inside Mainland China, Hong Kong and Macau starting July 2015.

MWFC Global Ventures HK Ltd. &  A.S. Watson Industries
MWFC Global Ventures HK Ltd. & A.S. Watson Industries

“I am so excited to have such a prestigious partner as A.S.  Watson’s in this project, they have almost 200 years of leading beverage experience in Asia.” explains Mike Miller, both a member in Let It Fly Energy, LLC and MWFC Global Ventures (HK) Ltd. “When my friend and business partner, Curt Flaitz, found this venture feasible, he brought it over to the Waters Group who then nurtured the deal. I was impressed by the magnitude of volume their groups negotiated. To have this happen with such an amazing team, in such a quick timeframe, is a real testament to A.S. Watson’s belief in L.I.F.E. and my team’s commitment to quality first expansion into Asia“.

L.I.F.E. Energy Original Can
L.I.F.E. Energy Original Can

The agreement calls on ASWI to sell and distribute L.I.F.E. beverages in the form of cans and bottles in The People’s Republic of China, Hong Kong and Macau. Over the next three years the deal monetizes to well overUSD$100 million in revenue.  ASWI’s parent company A.S. Watson Group is a member of the world renowned multinational conglomerate Hutchison Whampoa Limited chaired by Asia’s richest person Li Ka-Shing. Business interests include; ports, property, hotels, retail, infrastructure, energy and telecommunications in over 50 countries.  A.S. Watson Group is Asia’s largest health & beauty retailer under the Group’s flagship brand Watsons, currently operating over 4,500 stores and more than 1,200 pharmacies worldwide. The Group has one of the world’s largest portfolios of retail formats, retail brands, and geographical presences supported by a global family of over 110,000 staff.

2X NBA Champion Mike Miller
2X NBA Champion Mike Miller

“Having L.I.F.E. in our distribution platform is an important accomplishment for our group,” explains a top personnel for ASWI, “Understanding the marketing strength the brand maintains was a very important element to our groups inclusion of L.I.F.E. in our portfolio for the next three years.”

Christian Waters, CEO of the Waters Group LLC and Managing Partner at MWFC HK Ltd. explains the deal’s magnitude, “A.S. Watson’s China entity has never distributed a third party brand in their 187 years inside China. To have this distinguished company value L.I.F.E as their inaugural brand means a great deal to our group. ASWI’s ability to distribute to such a large geographical region should result in strong sell thru’s, creating elevated MWFC brand value and strong multiples.”

Curtis Flaitz from the Flaitz Group sums it up, “The opportunity is immense and knowing Mike for as long as I had I knew that with the correct partners we could really do something special in Asia for L.I.F.E. and Mike. I am excited with the upside this deal has”.

For further information on L.I.F.E. and MWFC HK Ltd. opportunities please contact :

Christian, , +852.5420.7760 or WhatsApp: +852.5420.7760

L.I.F.E. Energy & the Waters Group LLC
L.I.F.E. Energy & the Waters Group LLC

About L.I.F.E. : L.I.F.E. was launched in 2010 when Mike Miller was a member of the NBA Champion Miami Heat. The USA energy drink formula was originated so that Miller and his NBA teammates could consume the beverages at practice and during games. The healthy formulas were geared towards athlete’s specific needs during times of recuperation and high performance game situations. Miller’s L.I.F.E. beverage has since expanded globally, allowing L.I.F.E.’s formula’s to take on regional and cultural taste attributes. Miller remains loyally committed to growing his beverages globally through MWFC HK Ltd. bringing his unique vision and strong athlete backed marketing platform to emerging regions.

About MWFC Global Ventures (HK) Ltd. : MWFC was created by Mike Miller, Christian Waters, Curtis Flaitz and a beverage industry expert as the IP holding company for L.I.F.E. inside Asia, most recently executing a 3 year agreement for the beverage inside Hong Kong, Macau and China. Equally important MWFC was established as a uniquely robust entry point for Western Food & Beverage brands in which to lucratively launch into The People’s Republic of China. MWFC will be looking for strong capital partnerships in which to further their strong portfolio of beverage brands with inside SE Asia and globally.

About A.S. Watson Group, A.S. Watson Industries: The A.S. Watson Group is the largest health and beauty retail group in Hong Kong, with over 11,000 stores in 33 markets worldwide serving over 27 million customers per week. The retail giant serves more than 3 million customers on the Chinese mainland every week, and has issued more than 20 million membership cards nationwide. The group operates the world’s largest portfolio of retail formats, retail brands and has the largest geographical presence, and the company is majority owned by multinational conglomerate Hutchison Whampoa, with just over 75 percent. A.S. Watson Group is a Hutchison Whampoa Ltd company. Approximately half of its brand’s stores globally are in China. Watsons currently operates 2,000th store in China, projected to open its 3,000th by end of 2016. They maintains 100% coverage in Tier 1 China cities.

About The Waters Group, LLC : The Waters Group was created to bridge the gap between brands and entrepreneurs looking to enter China through strong partnership. The U.S. entity is focused on bridging relationships between Western brands, celebrities, organizations and athletes looking to partner and penetrate the Chinese market. Through solid and well-funded relationships the WATERS Group has been able to provide a gateway for those looking to bring their brand or “personal brand” to market inside China.  The WATERS group successfully negotiated and partnered MWFC Global Ventures Hong Kong Limited, the IP holder for L.I.F.E. Energy, with A.S. Watson Industries and A.S. Watson Group.

Photo –
Photo –
Photo –
Photo –

Source: MWFC Global Ventures Hong Kong Limited

Written by asiafreshnews

May 13, 2015 at 11:19 am

Posted in Uncategorized